Article Versions Notes

Lehot V, Neuberg P, Ripoll M, Daubeuf F, Erb S, Dovgan I, Ursuegui S, Cianférani S, Kichler A, Chaubet G, et al. Targeted Anticancer Agent with Original Mode of Action Prepared by Supramolecular Assembly of Antibody Oligonucleotide Conjugates and Cationic Nanoparticles. Pharmaceutics. 2023; 15(6):1643. https://doi.org/10.3390/pharmaceutics15061643

Lehot, Victor, Patrick Neuberg, Manon Ripoll, François Daubeuf, Stéphane Erb, Igor Dovgan, Sylvain Ursuegui, Sarah Cianférani, Antoine Kichler, Guilhem Chaubet, and et al. 2023. "Targeted Anticancer Agent with Original Mode of Action Prepared by Supramolecular Assembly of Antibody Oligonucleotide Conjugates and Cationic Nanoparticles" Pharmaceutics 15, no. 6: 1643. https://doi.org/10.3390/pharmaceutics15061643

Lehot, V., Neuberg, P., Ripoll, M., Daubeuf, F., Erb, S., Dovgan, I., Ursuegui, S., Cianférani, S., Kichler, A., Chaubet, G., & Wagner, A. (2023). Targeted Anticancer Agent with Original Mode of Action Prepared by Supramolecular Assembly of Antibody Oligonucleotide Conjugates and Cationic Nanoparticles. Pharmaceutics, 15(6), 1643. https://doi.org/10.3390/pharmaceutics15061643